Elevated ALT, AST, and ALP are associated with non-alcoholic fatty liver disease and non-alcoholic steatohepatitis [37]; these enzymes were significantly reduced with intervention. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.